Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
84636152 | 8463615 | 2 | F | 20120311 | 20120315 | 20120316 | 20120316 | PER | US-PFIZER INC-2012068871 | PFIZER | 76.12 | YR | F | Y | 59.00000 | KG | 20120316 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
84636152 | 8463615 | 1 | PS | CHANTIX | 1 | ORAL | 0.5 MG, 1X/DAY | 21928 | 1 | MG | FILM-COATED TABLET | ||||||||
84636152 | 8463615 | 2 | C | NEURONTIN | 1 | UNK | 0 | ||||||||||||
84636152 | 8463615 | 3 | C | METFORMIN | 1 | UNK | 0 | ||||||||||||
84636152 | 8463615 | 4 | C | GLIPIZIDE | 1 | UNK | 0 | ||||||||||||
84636152 | 8463615 | 5 | C | OXYCODONE | 1 | UNK | 0 | ||||||||||||
84636152 | 8463615 | 6 | C | AMITRIPTYLINE | 1 | UNK | 0 | ||||||||||||
84636152 | 8463615 | 7 | C | LISINOPRIL | 1 | UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
84636152 | 8463615 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
84636152 | 8463615 | BLOOD GLUCOSE INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
84636152 | 8463615 | 1 | 20120310 | 0 |